Autolus Therapeutics PLC (AUTL)
3.34
-0.16
(-4.57%)
USD |
NASDAQ |
Nov 04, 16:00
3.345
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Market Cap: 890.09M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 931.33M |
| October 31, 2024 | 896.74M |
| October 30, 2024 | 1.064B |
| October 29, 2024 | 1.155B |
| October 28, 2024 | 1.211B |
| October 25, 2024 | 1.181B |
| October 24, 2024 | 1.181B |
| October 23, 2024 | 1.189B |
| October 22, 2024 | 1.181B |
| October 21, 2024 | 1.203B |
| October 18, 2024 | 1.277B |
| October 17, 2024 | 1.251B |
| October 16, 2024 | 1.200B |
| October 15, 2024 | 1.134B |
| October 14, 2024 | 1.112B |
| October 11, 2024 | 1.102B |
| October 10, 2024 | 1.094B |
| October 09, 2024 | 1.059B |
| October 08, 2024 | 1.080B |
| October 07, 2024 | 1.040B |
| October 04, 2024 | 1.059B |
| October 03, 2024 | 1.038B |
| October 02, 2024 | 1.056B |
| October 01, 2024 | 957.94M |
| September 30, 2024 | 965.92M |
| Date | Value |
|---|---|
| September 27, 2024 | 965.92M |
| September 26, 2024 | 926.01M |
| September 25, 2024 | 918.03M |
| September 24, 2024 | 933.99M |
| September 23, 2024 | 931.33M |
| September 20, 2024 | 992.53M |
| September 19, 2024 | 1.024B |
| September 18, 2024 | 1.030B |
| September 17, 2024 | 1.022B |
| September 16, 2024 | 1.064B |
| September 13, 2024 | 1.086B |
| September 12, 2024 | 1.051B |
| September 11, 2024 | 1.088B |
| September 10, 2024 | 1.096B |
| September 09, 2024 | 1.088B |
| September 06, 2024 | 1.066B |
| September 05, 2024 | 1.181B |
| September 04, 2024 | 1.091B |
| September 03, 2024 | 1.024B |
| August 30, 2024 | 1.046B |
| August 29, 2024 | 1.014B |
| August 28, 2024 | 1.043B |
| August 27, 2024 | 1.046B |
| August 26, 2024 | 1.056B |
| August 23, 2024 | 1.062B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
161.30M
Minimum
Dec 12 2022
1.742B
Maximum
Mar 20 2024
577.88M
Average
477.62M
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 208.38M |
| Biodexa Pharmaceuticals PLC | 3.299M |
| NuCana PLC | 3.482M |
| TC BioPharm (Holdings) PLC | 0.6923M |
| Verona Pharma PLC | 3.101B |
Market Cap Related Metrics
| Price to Book Value | 1.686 |
| Price | 3.34 |
| Earnings Yield | -34.98% |